Human Molecular Genetics Advance Access originally published online on January 6, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, No. 4 367-378
DOI: 10.1093/hmg/ddh044
Behavioral characterization of mouse models for SmithMagenis syndrome and dup(17)(p11.2p11.2)
1Department of Molecular and Human Genetics and 2Department of Pediatrics, 3Division of Neurosciences, Baylor College of Medicine, Houston, TX 77030, USA and 4Texas Children's Hospital, Houston, TX 77030, USA
Received September 22, 2003; Accepted December 10, 2003
Contiguous gene syndromes (CGS) refer to a group of disorders associated with chromosomal rearrangements in which the phenotype is thought to result from altered copy number of physically linked dosage-sensitive genes. SmithMagenis syndrome and [dup(17)(p11.2p11.2)] are CGS associated with a heterozygous deletion or duplication of band p11.2 of chromosome 17, respectively. We previously constructed animal models for these CGSs by engineering rearranged chromosomes carrying a deletion/deficiency [Df(11)17] (Del mutant) or a duplication [Dp(11)17 ] (Dup mutant) of the syntenic region on mouse chromosome 11. Here we present a behavioral analysis of these models indicating that heterozygous male mice carrying the engineered deletion or the duplication are hypoactive or hyperactive, respectively. In addition, male Dup mutant mice, but not Del mutant mice, have impaired contextual fear conditioning. Circadian rhythm studies revealed period length differences in Del mutant mice, but not Dup mutant mice. These results indicate that some of the behavioral abnormalities are gene dosage sensitive, whereas other behavioral abnormalities are specific to mice carrying the deletion or the duplication and can be observed in a sex preferential manner. Our findings suggest that there is a gene(s) present in this defined genomic interval that is responsible for behavioral abnormalities in the mouse, as has been shown for the human syntenic region.
* To whom correspondence should be addressed. Tel: +1 7137986124; Fax: +1 7137987773; Email: rpaylor{at}bcm.tmc.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Molina, P. Carmona-Mora, J. Chrast, P. M. Krall, C. P. Canales, J. R. Lupski, A. Reymond, and K. Walz Abnormal social behaviors and altered gene expression rates in a mouse model for Potocki-Lupski syndrome Hum. Mol. Genet., August 15, 2008; 17(16): 2486 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bi, J. Yan, X. Shi, L. A. Yuva-Paylor, B. A. Antalffy, A. Goldman, J. W. Yoo, J. L. Noebels, D. L. Armstrong, R. Paylor, et al. Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes Hum. Mol. Genet., August 1, 2007; 16(15): 1802 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Goldman, L. Potocki, K. Walz, J. K. Lynch, D. G. Glaze, J. R. Lupski, and J. L. Noebels Topical Review: Epilepsy and Chromosomal Rearrangements in Smith-Magenis Syndrome [del(17)(p11.2p11.2)] J Child Neurol, February 1, 2006; 21(2): 93 - 98. [Abstract] [PDF] |
||||
![]() |
W. Bi, T. Ohyama, H. Nakamura, J. Yan, J. Visvanathan, M. J. Justice, and J. R. Lupski Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome Hum. Mol. Genet., April 15, 2005; 14(8): 983 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yan, V. W. Keener, W. Bi, K. Walz, A. Bradley, M. J. Justice, and J. R. Lupski Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome Hum. Mol. Genet., November 1, 2004; 13(21): 2613 - 2624. [Abstract] [Full Text] [PDF] |
||||

